Chih-Hsuan Hsia

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Fluorescent Probe

Gold Nanoparticles

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chih-Hsuan Hsia, Thanasekaran Jayakumar, Kuan Hung Lin, Joen-Rong Sheu, Chih-Wei Hsia, Periyakali Saravana Bhavan, Manjunath Manubolu, Wei-Chieh Huang, Yi Chang
Corrigendum to "Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF- κ B/MAPKs Signaling Pathways". Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Chih-Hsuan Hsia, Thanasekaran Jayakumar, Kuan Hung Lin, Joen-Rong Sheu, Chih-Wei Hsia, Periyakali Saravana Bhavan, Manjunath Manubolu, Wei-Chieh Huang, Yi Chang
Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Chih-Hsuan Hsia, Wan-Jung Lu, Kuan-Hung Lin, Duen-Suey Chou, Pitchairaj Geraldine, Thanasekaran Jayakuma, Nen-Chung Chang, Joen-Rong Sheu
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIb β3 binding in human platelets. Journal of cellular and molecular medicine 22 (4) (2018)